Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Understanding Zimbabwe's pharmacovigilance system

Liberty Chirinda - Medicines Control Authority of Zimbabwe, Harare, Zimbabwe
Understanding Zimbabwe's pharmacovigilance system ( Liberty Chirinda - Medicines Control Authority of Zimbabwe, Harare, Zimbabwe )
4 Jun 2025

ASCO 2025: Importance of early testing in metastatic prostate cancer

Prof Eleni Efstathiou, Dr Elena Castro, Prof Gerhardt Attard and Dr Brigida Maiorano
ASCO 2025: Importance of early testing in metastatic prostate cancer ( Prof Eleni Efstathiou, Dr Elena Castro, Prof Gerhardt Attard and Dr Brigida Maiorano )
3 Jun 2025

Sacituzumab govitecan shows efficacy signals in muscle-invasive urothelial bladder cancer

Dr Brigida Maiorano - IRCCS San Raffaele Hospital, Milan, Italy
Sacituzumab govitecan shows efficacy signals in muscle-invasive urothelial bladder cancer ( Dr Brigida Maiorano - IRCCS San Raffaele Hospital, Milan, Italy )
3 Jun 2025

Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective

Dr Ricky Frazer and Dr Sree Subramanian
Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective ( Dr Ricky Frazer and Dr Sree Subramanian )
19 May 2025

ELCC 2025: Latest in EGFR positive NSCLC

Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom
ELCC 2025: Latest in EGFR positive NSCLC ( Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom )
25 Apr 2025

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC

Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany
Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC ( Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany )
10 Apr 2025

Dermatologic adverse events in the treatment of NSCLC with amivantamab plus lazertinib significantly reduced

Prof Nicolas Girard - Institut Curie, Paris, France
Dermatologic adverse events in the treatment of NSCLC with amivantamab plus lazertinib significantly reduced ( Prof Nicolas Girard - Institut Curie, Paris, France )
7 Apr 2025

Consolidation durvalumab after cCRT shows decreased disease progression in LS-SCLC

Prof Suresh Senan - University Medical Centers, Amsterdam, The Netherlands
Consolidation durvalumab after cCRT shows decreased disease progression in LS-SCLC ( Prof Suresh Senan - University Medical Centers, Amsterdam, The Netherlands )
7 Apr 2025

Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC

Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada
Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC ( Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada )
27 Mar 2025

Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients

Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston, USA
Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients ( Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston, USA )
11 Mar 2025

Intraoperative radiotherapy for brain tumours

Dr Douglas Guedes - Alemão Oswaldo Cruz Hospital, São Paulo, Brazil
Intraoperative radiotherapy for brain tumours ( Dr Douglas Guedes - Alemão Oswaldo Cruz Hospital, São Paulo, Brazil )
10 Mar 2025

SIOG 2024: Updates in medical oncology

Dr Capucine Baldini - Gustave Roussy, Villejuif, France
SIOG 2024: Updates in medical oncology ( Dr Capucine Baldini - Gustave Roussy, Villejuif, France )
19 Feb 2025